Quantum BioPharma Announces Q3 Results: Crypto Asset Portfolio Profits Reach $572,000

Jinse Finance reported that Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial position. Shareholders' equity increased by 275% quarter-on-quarter, total liabilities decreased by 50%, and the debt-to-equity ratio dropped by 87%. The company's digital asset portfolio (mainly bitcoin) has realized a profit of $572,000, with the total value of digital assets rising from $800,000 at the end of 2024 to the current $5.2 million.